Ubs Asset Management Americas Inc Arbutus Biopharma Corp Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,072,744 shares of ABUS stock, worth $3.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,072,744
Previous 114,950
833.23%
Holding current value
$3.65 Million
Previous $401,000
726.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABUS
# of Institutions
182Shares Held
118MCall Options Held
982KPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$82.2 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$45.4 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$39.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$35.5 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$30.9 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $510M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...